Estimating the rate of overdiagnosis with prostate cancer screening: evidence from the Finnish component of the European Randomized Study of Screening for Prostate Cancer-Reference-Cited by-同舟云学术

Estimating the rate of overdiagnosis with prostate cancer screening: evidence from the Finnish component of the European Randomized Study of Screening for Prostate Cancer

Published:2021-07-27 Issue:11 Volume:32 Page:1299-1313
ISSN:0957-5243
Container-title:Cancer Causes & Control
language:en
Short-container-title:Cancer Causes Control

Author:

Walter S. D.^ORCID,Hu Jiarui,Talala Kirsi,Tammela Teuvo,Taari Kimmo,Auvinen Anssi

Funder

Natural Sciences and Engineering Research Council of Canada

the Academy of Finland

the Cancer Society of Finland

Competitive State Research Funding administered by Pirkanmaa University Hospital special responsibility area.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10552-021-01480-8.pdf

Reference34 articles.

1. Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A (2020) Recent global patterns in prostate cancer incidence and mortality rates. Eur Urol 77:38–52

2. American Cancer Society (2018) Cancer Facts & Figures 2017. American Cancer Society, Atlanta

3. Martin RM, Donovan JL, Turner EL et al (2018) Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trial. JAMA 319:883–895

4. Hoffman RM, Meisner ALW, Arap W, Barry M, Shah SK, Zeliadt SB, Wiggins CL (2016) Trends in United States prostate cancer incidence rates by age and stage, 1995–2012. Cancer Epidemiol Biomar Prev 25:259–263

5. Andriole GL, et al., PLCO Project Team (2009) Mortality results from a randomized prostate cancer screening trial. New Engl J Med 360: 1310–1319

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostatakarzinom-Screening? Nur evidenzbasiert, risikoadaptiert und organisiert!;Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz;2024-08-05

2. Relative risk of second malignant neoplasms highest among young adult cancer patients – a population-based registry study in Finland;Acta Oncologica;2024-06-08

3. Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis;Cancer Medicine;2024-03-28

4. Application and optimization of prostate-specific antigen screening strategy in the diagnosis of prostate cancer: a systematic review;Frontiers in Oncology;2024-01-09

5. Data-driven overdiagnosis definitions: A scoping review;Journal of Biomedical Informatics;2023-11